B-Cell Infiltrates Induce Endosteal Bone Formation in Inflammatory Arthritis
- 1 October 2008
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 23 (10), 1650-1660
- https://doi.org/10.1359/jbmr.080508
Abstract
The objective of this study was to investigate the function of inflammatory bone marrow infiltrates found in vicinity to joints affected by inflammatory arthritis. These bone marrow infiltrates are rich in B cells and emerge at the interphase between bone marrow and synovial inflammatory tissue, where cortical bone has been broken. We deleted an essential molecule of B-cell development, Brutońs tyrosine kinase (Btk), in arthritic TNF-transgenic mice and studied its effect on bone marrow inflammation. Although antigen responses, immunoglobulin levels, and autoantibody production were diminished in Btk(-/-)hTNFtg mice, synovial inflammation developed normally. However, bone marrow infiltrates were significantly diminished in Btk(-/-)hTNFtg mice, which lead to impaired bone formation at endosteal sites underneath bone erosions and an increased invasion of synovial inflammatory cells into the bone marrow. Expression of bone morphogenic protein-7 was dramatically decreased in Btk(-/-)hTNFtg mice. These results do not only indicate that bone formation at endosteal regions next to bone marrow infiltrates is driven by B cells but also show that bone marrow aggregates in the vicinity of inflamed joint appear as an attempt to counter the invasion of inflammatory tissue into the bone marrow.Keywords
This publication has 23 references indexed in Scilit:
- Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitisArthritis & Rheumatism, 2006
- B cells move to centre stage: novel opportunities for autoimmune disease treatmentNature Reviews Drug Discovery, 2006
- The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trialArthritis & Rheumatism, 2006
- Mechanisms of Disease: the link between RANKL and arthritic bone diseaseNature Clinical Practice Rheumatology, 2005
- Involvement of subchondral bone marrow in rheumatoid arthritis: Lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitmentArthritis & Rheumatism, 2005
- Bone Morphogenetic ProteinsGrowth Factors, 2004
- The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspectiveImmunological Reviews, 2000
- Autoantibodies to the A/B Proteins of the Heterogeneous Nuclear Ribonucleoprotein Complex: Novel Tools for the Diagnosis of Rheumatic DiseasesInternational Archives of Allergy and Immunology, 1996
- Mutation of Unique Region of Bruton's Tyrosine Kinase in Immunodeficient XID MiceScience, 1993
- Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemiaCell, 1993